Aura Biosciences, Inc.
NASDAQ: AURA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Elisabet de los Pinos
- Employees
- 106
- Headquarters
- Boston, United States
- IPO year
- 2021
- Market cap
- $452.0M
- Website
- https://www.aurabiosciences.com
Loading AURA…
Loading profile data…Frequently asked questions about AURA
What does Aura Biosciences, Inc. (AURA) do?
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic...
Where does AURA trade?
Aura Biosciences, Inc. (AURA) trades on the NASDAQ Global Market.
What sector is AURA in?
Aura Biosciences, Inc. (AURA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aura Biosciences, Inc.?
Elisabet de los Pinos is the chief executive officer of Aura Biosciences, Inc. (AURA).
Where is Aura Biosciences, Inc. headquartered?
Aura Biosciences, Inc. is headquartered in United States.
Does AURA pay a dividend?
Aura Biosciences, Inc. (AURA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AURA go public?
Aura Biosciences, Inc. (AURA) completed its initial public offering in 2021.